<DOC>
	<DOCNO>NCT02062346</DOCNO>
	<brief_summary>Patients vasculitis commonly develop high blood pressure ( hypertension ) associate increase risk heart disease . It thus important low blood pressure hypertension . However , hypertension vasculitis inadequately control many currently available blood pressure lower agent . Endothelin chemical produce blood vessel contribute development hypertension . Higher normal level endothelin see patient vasculitis . By use drug block effect endothelin ( 'endothelin receptor antagonist ' ) investigator hopefully treat hypertension patient vasculitis . The purpose study ascertain whether endothelin receptor antagonist low blood pressure improve blood vessel function effectively patient vasculitis without .</brief_summary>
	<brief_title>Endothelin Antagonism ANCA Vasculitis</brief_title>
	<detailed_description>Vasculitis patient - match age , BP renal function - recruit 3 group define induction immunosuppression : ( ) Azathioiprine , ( ii ) Mycophenolate mofetil , ( iii ) Rituximab . A 4th group comprise control healthy subject ( n=10 ) . Subjects attend 4 study day &gt; 1 week apart . Circulating Mφ immune cell confirm use FACS prior study . Day 1 : assessment vascular function . Days 2 , 3 &amp; 4 ( randomise &amp; infusion give double-blind method ) : comparison effect selective ETA receptor antagonism ( BQ123 ; 1000nmol/min 15min iv ) , mixed ETA/B antagonism ( BQ123/788 ; 1000 nmol/min &amp; 300 nmol/min 15 min ) , placebo systemic haemodynamics . Outcome measure - Forearm blood flow - tPA release - Blood pressure - Aix &amp; PWV</detailed_description>
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>cyclo ( Trp-Asp-Pro-Val-Leu )</mesh_term>
	<criteria>Male female Age 1880 Body mass index ≤35 Normal serum albumin Subject age legal consent , mentally legally incapacitated History multiple and/or severe allergic reaction drug ( include study drug ) , food The subject donate blood ( 450 ml ) within last 4 week Past present drug alcohol abuse include intravenous drug abuse time Participation another clinical trial within 1 month Considered high risk HIV hepatitis B Women childbearing potential ( woman postmenopausal surgicallysterilised included study )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>endothelin ;</keyword>
	<keyword>blood pressure ;</keyword>
	<keyword>vasculitis</keyword>
</DOC>